Efficacy and safety of high dose VS low dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pnacreatitis:a randomized controlled multicenter trial
Not Applicable
Recruiting
- Conditions
- post ERCP pancreatitis
- Registration Number
- JPRN-UMIN000020457
- Lead Sponsor
- Kyoto Katsura Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
emergency ERCP from 17:30 to 8:30 eGFR<50 choledocholithiasis with pancreatitis aspirin induced asthma pregnancy Triamterene oral administration <20age shock vital NSAIDs allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method on inferiority of Low dose VS high dose rectal diclofenac for prevention of post ERCP pancreatitis
- Secondary Outcome Measures
Name Time Method severity of pancreatitis adverse event serum AMY level 2 hours and one day after ERCP Spread of inflamation in serum AMY high level